Dr. Isabel Arrillaga-Romany, MD, Ph.D
Claim this profileMassachusetts General Hospital
Studies Brain Tumor
Studies Glioblastoma
6 reported clinical trials
11 drugs studied
Area of expertise
1Brain Tumor
IDH positive
H3 K27M positive
Stage IV
2Glioblastoma
IDH negative
EGFR positive
TERT positive
Affiliated Hospitals
Clinical Trials Isabel Arrillaga-Romany, MD, Ph.D is currently running
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3
Pembro + Olaparib with TMZ
for Recurrent Glioblastoma
This trial is testing a combination of three drugs to treat brain tumors that have come back after previous treatments. The drugs help the immune system attack the tumor, stop the tumor cells from repairing themselves, and prevent them from growing. About 66-78 people will participate in this study.
Recruiting1 award Phase 210 criteria
More about Isabel Arrillaga-Romany, MD, Ph.D
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Isabel Arrillaga-Romany, MD, Ph.D has experience with
- ASTX727
- Niraparib
- Resection/Treatment With Niraparib
- Abemaciclib
- Surgery
- Olaparib
Breakdown of trials Isabel Arrillaga-Romany, MD, Ph.D has run
Central Nervous System Tumor
Malignant Glioma
Isocitrate Dehydrogenase 1
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Isabel Arrillaga-Romany, MD, Ph.D specialize in?
Isabel Arrillaga-Romany, MD, Ph.D focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are H3 K27M positive.
Is Isabel Arrillaga-Romany, MD, Ph.D currently recruiting for clinical trials?
Yes, Isabel Arrillaga-Romany, MD, Ph.D is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Isabel Arrillaga-Romany, MD, Ph.D has studied deeply?
Yes, Isabel Arrillaga-Romany, MD, Ph.D has studied treatments such as ASTX727, Niraparib, Resection/Treatment with Niraparib.
What is the best way to schedule an appointment with Isabel Arrillaga-Romany, MD, Ph.D?
Apply for one of the trials that Isabel Arrillaga-Romany, MD, Ph.D is conducting.
What is the office address of Isabel Arrillaga-Romany, MD, Ph.D?
The office of Isabel Arrillaga-Romany, MD, Ph.D is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.